Albion Financial Group’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-50
Closed -$5.04K 744
2025
Q4
$5.04K Sell
50
-254
-84% -$27.6K ﹤0.01% 467
2025
Q3
$37.5K Sell
304
-34,585
-99% -$4.29M ﹤0.01% 281
2025
Q2
$4.19M Buy
34,889
+115
+0.3% +$15.3K 0.27% 70
2025
Q1
$5.12M Buy
34,774
+2,669
+8% +$408K 0.36% 62
2024
Q4
$5.21M Sell
32,105
-284
-0.9% -$46.5K 0.36% 56
2024
Q3
$5.28M Buy
32,389
+991
+3% +$147K 0.37% 58
2024
Q2
$4.28M Buy
31,398
+152
+0.5% +$21.1K 0.32% 58
2024
Q1
$4.78M Buy
31,246
+1,712
+6% +$256K 0.37% 55
2023
Q4
$4.21M Sell
29,534
-1,011
-3% -$135K 0.35% 58
2023
Q3
$4M Buy
30,545
+2,498
+9% +$380K 0.37% 56
2023
Q2
$4.46M Buy
28,047
+61
+0.2% +$9.84K 0.39% 56
2023
Q1
$4.43M Buy
27,986
+382
+1% +$57.3K 0.41% 56
2022
Q4
$3.87M Sell
27,604
-4
-0% -$568 0.37% 57
2022
Q3
$3.54M Buy
27,608
+205
+0.7% +$29.6K 0.37% 59
2022
Q2
$3.86M Sell
27,403
-215
-0.8% -$30.7K 0.38% 59
2022
Q1
$3.84M Buy
27,618
+1,341
+5% +$205K 0.33% 61
2021
Q4
$4.58M Sell
26,277
-2,340
-8% -$390K 0.36% 59
2021
Q3
$4.74M Buy
28,617
+200
+0.7% +$34.4K 0.42% 55
2021
Q2
$5.11M Buy
+28,417
New +$5.19M 0.44% 49
2020
Q4
$5.76M Buy
28,527
+733
+3% +$152K 0.56% 42
2020
Q3
$5.84M Sell
27,794
-212
-0.8% -$47.2K 0.63% 39
2020
Q2
$6.14M Buy
28,006
+370
+1% +$73.9K 0.73% 31
2020
Q1
$4.79M Buy
27,636
+156
+0.6% +$25.8K 0.7% 33
2019
Q4
$4.22M Buy
27,480
+188
+0.7% +$28.1K 0.5% 47
2019
Q3
$4.14M Sell
27,292
-105
-0.4% -$16.6K 0.53% 45
2019
Q2
$4.2M Buy
27,397
+36
+0.1% +$5.5K 0.54% 42
2019
Q1
$4.39M Sell
27,361
-139
-0.5% -$21.6K 0.6% 40
2018
Q4
$4.24M Buy
27,500
+292
+1% +$45.5K 0.66% 37
2018
Q3
$4.09M Sell
27,208
-3,014
-10% -$428K 0.55% 42
2018
Q2
$4.09M Buy
30,222
+263
+0.9% +$32.5K 0.59% 39
2018
Q1
$3.99M Sell
29,959
-78
-0.3% -$10.5K 0.61% 36
2017
Q4
$4.47M Sell
30,037
-384
-1% -$52.2K 0.68% 35
2017
Q3
$4.01M Sell
30,421
-1,104
-4% -$148K 0.61% 41
2017
Q2
$4.2M Sell
31,525
-2,489
-7% -$336K 0.7% 35
2017
Q1
$4.59M Sell
34,014
-999
-3% -$129K 0.69% 34
2016
Q4
$4.2M Sell
35,013
-745
-2% -$87.9K 0.7% 31
2016
Q3
$4.48M Sell
35,758
-3,871
-10% -$507K 0.77% 34
2016
Q2
$5.48M Buy
39,629
+436
+1% +$56.5K 0.99% 23
2016
Q1
$4.94M Sell
39,193
-2,990
-7% -$380K 0.84% 23
2015
Q4
$5.35M Sell
42,183
-350
-0.8% -$43.4K 0.92% 25
2015
Q3
$4.91M Buy
42,533
+689
+2% +$77.3K 0.89% 24
2015
Q2
$4.35M Sell
41,844
-330
-0.8% -$35.6K 0.72% 27
2015
Q1
$4.66M Sell
42,174
-315
-0.7% -$34.2K 0.79% 25
2014
Q4
$4.43M Buy
42,489
+2
+0% +$200 0.76% 26
2014
Q3
$4.08M Buy
42,487
+476
+1% +$43K 0.72% 28
2014
Q2
$3.84M Buy
42,011
+1,640
+4% +$147K 0.66% 34
2014
Q1
$3.55M Buy
40,371
+1,012
+3% +$88.8K 0.66% 33
2013
Q4
$3.65M Buy
39,359
+2,841
+8% +$256K 0.68% 33
2013
Q3
$2.98M Buy
36,518
+2,800
+8% +$236K 0.64% 33
2013
Q2
$2.8M Buy
+33,718
New +$2.9M 0.62% 34

Other funds holding CLX

Albion Financial Group's CLX Position: Q1 2026 in Review

Albion Financial Group sold out of Clorox (CLX) in Q1 2026, closing a stake of 50 shares — an estimated $5.04K sold.

Albion Financial Group first reported a position in CLX in Q2 2013 and held it in 50 quarters. The position peaked at $6.14M in Q2 2020. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Albion Financial Group reported no remaining Clorox position as of Q1 2026 after selling out during the quarter.
  • Albion Financial Group sold 50 Clorox shares in Q1 2026, an estimated $5.04K.
  • Albion Financial Group first reported a position in Clorox in Q2 2013 and held it in 50 quarters.
  • Albion Financial Group's Clorox position peaked at $6.14M in Q2 2020.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Albion Financial Group's 13F filing for Q1 2026, filed 27 Apr 2026.